Summit Therapeutics IncNASDAQ:SMMT
- LAST PRICE4.6850
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots4.7100/ 1
- Ask / Lots4.9000/ 2
- Open / Previous Close0.0000 / 4.6850
- Day Range---
- 52 Week Range
- Volume213
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SMMT |
|---|---|---|
| 09:32 ET | 65990 | 5 |
| 09:34 ET | 17703 | 5.0657 |
| 09:36 ET | 13721 | 5.04 |
| 09:38 ET | 68457 | 5.02 |
| 09:39 ET | 10447 | 5.005 |
| 09:41 ET | 6175 | 5.02 |
| 09:43 ET | 5501 | 5.015 |
| 09:45 ET | 5921 | 5 |
| 09:48 ET | 10447 | 5.02 |
| 09:50 ET | 6080 | 5.06 |
| 09:52 ET | 19349 | 5.075 |
| 09:54 ET | 12274 | 5.08 |
| 09:56 ET | 4463 | 5.0699 |
| 09:57 ET | 9442 | 5.07 |
| 09:59 ET | 41324 | 5.109 |
| 10:01 ET | 20156 | 5.07 |
| 10:03 ET | 6000 | 5.03 |
| 10:06 ET | 5841 | 5.05 |
| 10:08 ET | 5411 | 5.0545 |
| 10:10 ET | 9156 | 5.045 |
| 10:12 ET | 5921 | 5.03 |
| 10:14 ET | 5480 | 5.04 |
| 10:15 ET | 22589 | 5.025 |
| 10:17 ET | 4287 | 5.035 |
| 10:19 ET | 16486 | 4.995 |
| 10:21 ET | 2706 | 4.995 |
| 10:24 ET | 3339 | 5.015 |
| 10:26 ET | 7908 | 4.975 |
| 10:28 ET | 20216 | 4.915 |
| 10:30 ET | 6300 | 4.9 |
| 10:32 ET | 9437 | 4.92 |
| 10:33 ET | 6899 | 4.95 |
| 10:35 ET | 6706 | 4.972 |
| 10:37 ET | 2538 | 4.95 |
| 10:39 ET | 8638 | 4.965 |
| 10:42 ET | 10329 | 4.945 |
| 10:44 ET | 4094 | 4.9775 |
| 10:46 ET | 2929 | 4.95 |
| 10:48 ET | 4316 | 4.99 |
| 10:50 ET | 3890 | 5.015 |
| 10:51 ET | 14455 | 5 |
| 10:53 ET | 3970 | 5.01 |
| 10:55 ET | 4706 | 4.985 |
| 10:57 ET | 3250 | 4.9849 |
| 11:00 ET | 5711 | 4.99 |
| 11:02 ET | 10513 | 4.95 |
| 11:04 ET | 3512 | 4.965 |
| 11:06 ET | 3673 | 4.95 |
| 11:08 ET | 5164 | 4.935 |
| 11:09 ET | 4128 | 4.935 |
| 11:11 ET | 8542 | 4.93 |
| 11:13 ET | 2649 | 4.91 |
| 11:15 ET | 15739 | 4.88 |
| 11:18 ET | 6211 | 4.89 |
| 11:20 ET | 4152 | 4.89 |
| 11:22 ET | 5997 | 4.9 |
| 11:24 ET | 700 | 4.9 |
| 11:26 ET | 6878 | 4.885 |
| 11:27 ET | 3743 | 4.88 |
| 11:29 ET | 3752 | 4.885 |
| 11:31 ET | 12097 | 4.845 |
| 11:33 ET | 4543 | 4.85 |
| 11:36 ET | 12099 | 4.83 |
| 11:38 ET | 5712 | 4.83 |
| 11:40 ET | 5126 | 4.85 |
| 11:42 ET | 984 | 4.845 |
| 11:44 ET | 1000 | 4.845 |
| 11:45 ET | 3580 | 4.835 |
| 11:47 ET | 4120 | 4.84 |
| 11:49 ET | 2600 | 4.875 |
| 11:51 ET | 5267 | 4.89 |
| 11:54 ET | 2131 | 4.89 |
| 11:56 ET | 2606 | 4.9 |
| 11:58 ET | 2580 | 4.91 |
| 12:00 ET | 5225 | 4.9 |
| 12:02 ET | 7282 | 4.9 |
| 12:03 ET | 1396 | 4.9027 |
| 12:05 ET | 2157 | 4.895 |
| 12:07 ET | 8581 | 4.835 |
| 12:09 ET | 7803 | 4.855 |
| 12:12 ET | 5272 | 4.84 |
| 12:14 ET | 3227 | 4.84 |
| 12:16 ET | 5052 | 4.84 |
| 12:18 ET | 10089 | 4.8398 |
| 12:20 ET | 2520 | 4.815 |
| 12:21 ET | 5808 | 4.811 |
| 12:23 ET | 10426 | 4.805 |
| 12:25 ET | 3503 | 4.81 |
| 12:27 ET | 964 | 4.805 |
| 12:30 ET | 22076 | 4.75 |
| 12:32 ET | 4476 | 4.79 |
| 12:34 ET | 700 | 4.785 |
| 12:36 ET | 6183 | 4.805 |
| 12:38 ET | 20114 | 4.815 |
| 12:39 ET | 4775 | 4.8 |
| 12:41 ET | 4433 | 4.815 |
| 12:43 ET | 1400 | 4.8199 |
| 12:45 ET | 3875 | 4.77 |
| 12:48 ET | 4613 | 4.785 |
| 12:50 ET | 418 | 4.775 |
| 12:54 ET | 4877 | 4.79 |
| 12:56 ET | 200 | 4.8 |
| 12:59 ET | 616 | 4.8 |
| 01:01 ET | 2411 | 4.79 |
| 01:03 ET | 100 | 4.79 |
| 01:06 ET | 2959 | 4.795 |
| 01:08 ET | 3609 | 4.795 |
| 01:10 ET | 1138 | 4.785 |
| 01:12 ET | 1925 | 4.79 |
| 01:14 ET | 1100 | 4.795 |
| 01:15 ET | 8120 | 4.79 |
| 01:17 ET | 200 | 4.785 |
| 01:19 ET | 2485 | 4.795 |
| 01:21 ET | 2590 | 4.79 |
| 01:24 ET | 1500 | 4.785 |
| 01:26 ET | 2355 | 4.78 |
| 01:28 ET | 791 | 4.7851 |
| 01:30 ET | 5126 | 4.805 |
| 01:32 ET | 300 | 4.81 |
| 01:33 ET | 35833 | 4.795 |
| 01:35 ET | 1200 | 4.795 |
| 01:37 ET | 400 | 4.79 |
| 01:39 ET | 1908 | 4.79 |
| 01:42 ET | 3285 | 4.76 |
| 01:44 ET | 3177 | 4.76 |
| 01:46 ET | 3746 | 4.79 |
| 01:48 ET | 2581 | 4.79 |
| 01:51 ET | 1352 | 4.7827 |
| 01:53 ET | 500 | 4.785 |
| 01:55 ET | 400 | 4.78 |
| 01:57 ET | 900 | 4.78 |
| 02:00 ET | 500 | 4.78 |
| 02:02 ET | 9530 | 4.775 |
| 02:04 ET | 4224 | 4.775 |
| 02:06 ET | 1007 | 4.77 |
| 02:08 ET | 400 | 4.76 |
| 02:09 ET | 5530 | 4.775 |
| 02:11 ET | 1600 | 4.78 |
| 02:13 ET | 415 | 4.79 |
| 02:15 ET | 200 | 4.785 |
| 02:18 ET | 3378 | 4.785 |
| 02:20 ET | 100 | 4.79 |
| 02:22 ET | 400 | 4.78 |
| 02:24 ET | 7184 | 4.765 |
| 02:26 ET | 861 | 4.76 |
| 02:27 ET | 400 | 4.76 |
| 02:29 ET | 700 | 4.76 |
| 02:31 ET | 3621 | 4.785 |
| 02:33 ET | 600 | 4.785 |
| 02:36 ET | 400 | 4.785 |
| 02:38 ET | 577 | 4.785 |
| 02:40 ET | 2558 | 4.78 |
| 02:42 ET | 2479 | 4.785 |
| 02:45 ET | 3673 | 4.775 |
| 02:47 ET | 6080 | 4.77 |
| 02:49 ET | 10941 | 4.76 |
| 02:51 ET | 14896 | 4.73 |
| 02:54 ET | 400 | 4.73 |
| 02:56 ET | 840 | 4.73 |
| 02:58 ET | 3452 | 4.74 |
| 03:00 ET | 253 | 4.745 |
| 03:02 ET | 5898 | 4.765 |
| 03:03 ET | 5116 | 4.75 |
| 03:05 ET | 200 | 4.745 |
| 03:07 ET | 1018 | 4.745 |
| 03:09 ET | 2723 | 4.7425 |
| 03:12 ET | 3033 | 4.74 |
| 03:14 ET | 2070 | 4.735 |
| 03:16 ET | 1896 | 4.745 |
| 03:18 ET | 800 | 4.75 |
| 03:20 ET | 1179 | 4.745 |
| 03:21 ET | 7091 | 4.745 |
| 03:23 ET | 1244 | 4.735 |
| 03:25 ET | 3146 | 4.7424 |
| 03:27 ET | 400 | 4.75 |
| 03:30 ET | 900 | 4.745 |
| 03:32 ET | 14865 | 4.72 |
| 03:34 ET | 3663 | 4.73 |
| 03:36 ET | 1916 | 4.7275 |
| 03:38 ET | 4206 | 4.715 |
| 03:39 ET | 8199 | 4.715 |
| 03:41 ET | 6038 | 4.74 |
| 03:43 ET | 3917 | 4.745 |
| 03:45 ET | 13444 | 4.755 |
| 03:48 ET | 4450 | 4.75 |
| 03:50 ET | 8279 | 4.75 |
| 03:52 ET | 9218 | 4.77 |
| 03:54 ET | 15858 | 4.745 |
| 03:56 ET | 8562 | 4.74 |
| 03:57 ET | 57521 | 4.7 |
| 03:59 ET | 69296 | 4.685 |
May 7, 2024
DJ Summit Therapeutics Initiated at Buy by Citigroup, from 8:27AM ET on Tuesday May 07, 2024 by Dow Jones
8:27AM ET on Tuesday May 07, 2024 by Dow Jones
May 1, 2024
Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2024, from 7:00AM ET on Wednesday May 01, 2024 by Dow Jones
7:00AM ET on Wednesday May 01, 2024 by Dow Jones*DJ Summit Therapeutics 1Q Loss/Shr 6c >SMMT, from 7:00AM ET on Wednesday May 01, 2024 by Dow Jones
7:00AM ET on Wednesday May 01, 2024 by Dow Jones
Apr 24, 2024
Press Release: Summit Therapeutics to Host First Quarter 2024 Financial Results & Operational Progress Call on May 1, 2024, from 4:46PM ET on Wednesday Apr 24, 2024 by Dow Jones
4:46PM ET on Wednesday Apr 24, 2024 by Dow JonesSummit Therapeutics to Host First Quarter 2024 Financial Results & Operational Progress Call on May 1, 2024, from 4:30PM ET on Wednesday Apr 24, 2024 by Dow Jones
4:30PM ET on Wednesday Apr 24, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Summit Therapeutics Inc | 3.3B | -3.0x | --- |
Biohaven Ltd | 3.3B | -5.4x | --- |
SpringWorks Therapeutics Inc | 3.2B | -8.3x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Xenon Pharmaceuticals Inc | 3.1B | -15.0x | --- |
Apogee Therapeutics Inc | 3.0B | -31.1x | --- |
Company Information
Summit Therapeutics Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of patient, physician and caregiver medicinal therapies. The Company's development candidate is ivonescimab, a potential first-in-class bispecific antibody intending to combine the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects of an anti-VEGF compound into a single molecule. It develops ivonescimab in non-small cell lung cancer (NSCLC), specifically launching Phase III clinical trials in the indications such as ivonescimab combined with chemotherapy in patients with epidermal growth factor receptor (EGFR)-mutated, locally advanced or metastatic non-squamous NSCLC who have progressed after treatment with a third-generation EGFR tyrosine kinase inhibitor (HARMONi), and ivonescimab combined with chemotherapy in first-line metastatic squamous NSCLC patients (HARMONi-3). Its ivonescimab is engineered with Akeso's Tetrabody technology.
Contact Information
- Headquarters
- 2882 Sand Hill Road, Suite 106MENLO PARK, CA, United States 94025
- Phone
- 650-460-8308
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board, Co-Chief Executive Officer
- Robert Duggan
- President, Co-Chief Executive Officer, Director
- Mahkam Zanganeh
- Chief Financial Officer
- Ankur Dhingra
- Chief Operating Officer, Director
- Manmeet Soni
- Lead Non-Executive Independent Director
- Kenneth Clark
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.3B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 702.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -1.26 |
EPS | $-1.54 |
Book Value | $0.11 |
P/E Ratio | -3.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
